Mouse Anti-Human Pepsinogen II monoclonal antibody, clone 9213

Phase-generated carrier (PGC) demodulation algorithm is the main demodulation methods in Fiber-optic interferometric sensors (FOISs). The conventional PGC demodulation algorithms are influenced by the carrier phase delay between the interference signal and the carrier signal. In this paper, an automatic carrier phase delay synchronization (CPDS) algorithm based on orthogonal phase-locked technique is proposed. The proposed algorithm can calculate the carrier phase delay value. Then the carrier phase delay can be compensated by adjusting the initial phase of the fundamental carrier and the second-harmonic carrier. The simulation results demonstrate the influence of the carrier phase delay on the demodulation performance. PGC-Arctan demodulation system based on CPDS algorithm is implemented on SoC. The experimental results show that the proposed algorithm is able to obtain and eliminate the carrier phase delay. In comparison to the conventional demodulation algorithm, the signal-to-noise and distortion ratio (SINAD) of the proposed algorithm increases 55.99dB.

Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a transcriptional coactivator that binds to a diverse range of transcription factors. PPAR gamma coactivator 1 (PGC-1) coactivators possess an extensive range of biological effects in different tissues, and play a key part in the regulation of the oxidative metabolism, consequently modulating the production of reactive oxygen species, autophagy, and mitochondrial biogenesis. Owing to these findings, a large body of studies, aiming to establish the role of PGC-1 in the neuromuscular system, has shown that PGC-1 could be a promising target for therapies targeting neuromuscular diseases. Among these, some evidence has shown that various signaling pathways linked to PGC-1 alpha are deregulated in muscular dystrophy, leading to a reduced capacity for mitochondrial oxidative phosphorylation and increased reactive oxygen species (ROS) production. In the light of these results, any intervention aimed at activating PGC-1 could contribute towards ameliorating the progression of muscular dystrophies. PGC-1 alpha is influenced by different patho-physiological/pharmacological stimuli. Natural products have been reported to display modulatory effects on PPAR gamma activation with fewer side effects in comparison to synthetic drugs. Taken together, this review summarizes the current knowledge on Duchenne muscular dystrophy, focusing on the potential effects of natural compounds, acting as regulators of PGC-1 alpha. (C) 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.